表紙
市場調查報告書

成藥的全球市場的未來預測 (2018∼2028年):咳嗽、感冒、過敏藥,止痛藥,腸胃藥,皮膚藥,眼睛保健品用品,戒煙輔助品等

Global OTC Pharmaceutical Market Forecast 2019-2029: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

出版商 Visiongain Ltd 商品編碼 320889
出版日期 內容資訊 英文 212 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
成藥的全球市場的未來預測 (2018∼2028年):咳嗽、感冒、過敏藥,止痛藥,腸胃藥,皮膚藥,眼睛保健品用品,戒煙輔助品等 Global OTC Pharmaceutical Market Forecast 2019-2029: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others
出版日期: 2019年07月31日內容資訊: 英文 212 Pages
簡介

本報告提供全球成藥市場相關分析,產品、市場概要和最新趨勢,市場規模趨勢預測 (今後11年份),各產品、各地區的詳細趨勢,市場定性分析 (促進、阻礙因素,市場向心力等),主要企業的簡介,今後的市場成長可能性等彙整資料。

第1章 分析概要

第2章 成藥的概要

  • 成藥是什麼?
  • 成藥的分類
  • 成藥的必要條件
  • OTC交換器
  • 成藥的製造與流通
  • 成藥相關各國的法律規章

第3章 全球成藥市場預測 (今後11年份)

  • 成藥市場現狀

第4章 全球成藥市場:各產品的預測 (今後11年份)

  • 概要
  • 咳嗽,感冒,過敏
    • 抗過敏產品
  • 止痛藥 (內服藥物,外用藥)
  • 腸胃藥
  • 皮膚藥
    • 刀傷,外傷
    • 粉刺
    • 皮疹,癢,皮膚炎/濕疹
    • 皮膚真菌感染疾病
    • 痔核
    • 其他
  • 眼睛保健品用品
    • 乾眼症症候群
    • 細菌性結膜炎
    • 眼過敏/過敏性結膜炎
    • 眼過敏/過敏性結膜炎的治療藥
  • 戒煙輔助品
  • 其他

第5章 全球成藥市場:各地區、各國預測 (今後11年份)

  • 各地區的市場預測 (今後11年份)
  • 北美市場 (美國,加拿大,墨西哥)
  • 南美市場 (巴西,阿根廷,巴拉圭,玻利維亞等)
  • 歐洲市場 (法國,德國,英國,西班牙,義大利等)
  • 亞太地區市場 (日本,印度,澳洲,泰國等)
  • 其他的國家的市場 (RoW:中東,非洲等)

第6章 成藥市場定性分析

  • 成藥市場SWOT分析
  • 優勢
  • 弱點
  • 機會
  • 威脅
  • 波特的五力分析

第7章 成藥市場代表性企業

  • Bayer AG
  • GlaxoSmithKline PLC (GSK Consumer Care)
  • Johnson & Johnson
  • Perrigo Company PLC
  • 第一三共
  • Pfizer Inc.
  • Procter & Gamble
  • Sanofi S.A.
  • Reckitt Benckiser Group PLC
  • Cipla Inc.

第8章 結論

第9章 詞彙表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0459

The global OTC Pharmaceuticals market is estimated to be $162.64bn in 2018 and is expected to grow at a CAGR of 6.5% during the forecast period.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 212-page report you will receive 100 tables and 103 figures- all unavailable elsewhere.

The 212-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global OTC Pharmaceutical Market forecasts from 2019-2029

This report breaks down the revenue forecast of the Global OTC Pharmaceutical by product:

  • Analgesics
  • Cough, cold and allergy products
  • Dermatological products
  • Gastrointestinal products
  • Eye Care
  • Smoking Cessation Aids
  • Other products

Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and RoW

This report provides individual revenue forecasts to 2029 for these regional and national markets:

  • North America: the US, Canada, Mexico
  • South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
  • Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
  • Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
  • Rest of the World: Middle East, Africa, Other Countries

Each regional market is further broken down by product.

Our study provides a SWOT analysis and Porter's Five Forces analysis of the Global OTC Pharmaceutical market

This report discusses the leading companies in the Global OTC Pharmaceutical market

  • Bayer AG
  • Cipla, Inc.
  • Daiichi Sankyo Co., Ltd
  • GlaxoSmithKline (GSK) Consumer Care
  • Johnson & Johnson
  • Perrigo Company PLC
  • Pfizer Inc.
  • Procter & Gamble
  • Reckitt Benckiser Group PLC
  • Sanofi S.A

Key Questions Answered by this Report:

  • How is the OTC pharmaceuticals market evolving?
  • What is driving and restraining the OTC pharmaceuticals market growth?
  • What are the market shares of the leading segments within the OTC pharmaceuticals market in 2018?
  • How will the leading products in the OTC pharmaceuticals market grow over the forecast period and how much revenue will they account for in 2029?
  • Which therapies will be the main drivers of the overall market from 2018 to 2029?
  • How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
  • Who are the leading OTC pharmaceuticals companies, and what are their prospects over the forecast period?
  • What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants?

Visiongain's study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

Buy our report today Global OTC Pharmaceutical Market Forecast 2019-2029: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1 The OTC Pharmaceuticals Market Overview
  • 1.2 Research Methodology
    • 1.2.1 Secondary Research
    • 1.2.2 Market Evaluation & Forecasting Methodology
  • 1.3 Global OTC Pharmaceutical Market Segmentation
  • 1.4 Why You Should Read This Report
  • 1.5 How this report delivers?
  • 1.6 Key Questions Answered by This Analytical Report
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Who is This Report For?
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to OTC Pharmaceuticals

  • 2.1 What Are OTC Pharmaceuticals?
  • 2.2 Classification of OTC Pharmaceuticals
  • 2.3 What are the Requirements for an OTC Pharmaceutical Drug?
  • 2.4 OTC Switching
    • 2.4.1 How Is a Drug Switched from Prescription to OTC?
    • 2.4.2 Manufacturing and Distribution of OTC Pharmaceuticals
  • 2.5 Regulation of OTC Pharmaceuticals
    • 2.5.1 Regulation of OTC Pharmaceuticals in the US
    • 2.5.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
    • 2.5.3 Regulations of OTC Pharmaceuticals in Europe
    • 2.5.4 Regulation of OTC Pharmaceuticals in China
    • 2.5.5 Regulation of OTC Pharmaceuticals in Other Countries

3. Global OTC Pharmaceutical Market Forecast 2019-2029

  • 3.1 The Current State of the OTC Pharmaceuticals Market

4. Global OTC Pharmaceutical Market by Product: Market Forecast 2019 - 2029

  • 4.1 Overview
  • 4.2 Cough, Cold and Allergy
    • 4.2.1 Anti-Allergy Products
    • 4.2.2 Market size and forecast 2019-2029
  • 4.3 Analgesics
    • 4.3.1 Internal Analgesics
    • 4.3.2 External Analgesics
    • 4.3.3 Market size and forecast 2019-2029
  • 4.4 Gastrointestinal
    • 4.4.1 Market size and forecast 2019-2029
  • 4.5 Dermatological
    • 4.5.1 Minor Cuts and Wounds
    • 4.5.2 Acne
    • 4.5.3 Rashes, Itchy Skin, and Dermatitis/Eczema
    • 4.5.4 Cold Sores
    • 4.5.5 Warts
    • 4.5.6 Fungal Skin Infections
    • 4.5.7 Haemorrhoids
    • 4.5.8 Other Dermatological Products
    • 4.5.9 Market size and forecast 2018-2029
  • 4.6 Eye Care
    • 4.6.1 Dry Eye Syndrome
    • 4.6.2 Bacterial Conjunctivitis
    • 4.6.3 Ocular Allergy and Allergic Conjunctivitis
    • 4.6.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
    • 4.6.5 Market size and forecast 2019-2029
  • 4.7 Smoking Cessation Aids
    • 4.7.1 Market size and forecast 2019-2029
  • 4.8 Other Products
    • 4.8.1 Market size and forecast 2019-2029

5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2019 - 2029

  • 5.1 Global OTC Pharmaceuticals Market: Regional Forecast, 2019-2029
  • 5.2 North American OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.2.1 North American OTC Pharmaceuticals Market Forecasts by Country 2019-2029
    • 5.2.2 USA OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.2.3 Canada OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.2.4 Mexico OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.2.5 North American OTC Pharmaceuticals Market Forecasts by Product 2019-2029
  • 5.3 South American OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.3.1 South American OTC Pharmaceuticals Market Forecasts by Country 2019-2029
    • 5.3.2 Brazil OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.3.3 Argentina OTC Pharmaceutical Market Forecasts 2019-2029
    • 5.3.4 Paraguay OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.3.5 Bolivia OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.3.6 Rest of South America OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.3.7 South American OTC Pharmaceuticals Market Forecasts by Product 2019-2029
  • 5.4 European OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.4.1 Europe OTC Pharmaceuticals Market Forecasts by Country 2019-2029
    • 5.4.2 Germany OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.4.3 France OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.4.4 U.K. OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.4.5 Italy OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.4.6 Spain OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.4.7 Rest of Europe OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.4.8 Europe OTC Pharmaceuticals Market Forecasts by Product 2019-2029
  • 5.5 Asia-Pacific OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.5.1 Asia-Pacific OTC Pharmaceuticals Market Forecasts by Country 2019-2029
    • 5.5.2 Japan OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.5.3 China OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.5.4 India OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.5.5 Australia OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.5.6 Thailand OTC Pharmaceuticals Market Forecasts 2018-2029
    • 5.5.7 Rest of Asia-Pacific OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.5.8 Asia-Pacific OTC Pharmaceuticals Market Forecasts by Product 2018-2029
  • 5.6 Rest of the World OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.6.1 Rest of the World OTC Pharmaceuticals Market Forecasts by Country 2019-2029
    • 5.6.2 Middle East OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.6.3 Africa OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.6.4 Other Countries OTC Pharmaceuticals Market Forecasts 2019-2029
    • 5.6.5 Rest of the World OTC Pharmaceuticals Market Forecasts by Product 2019-2029

6. Qualitative Analysis of the OTC Pharmaceuticals Market

  • 6.1 SWOT Analysis of the OTC Pharmaceuticals Market
  • 6.2 Strengths
    • 6.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
  • 6.3 Weaknesses
    • 6.3.1 Pharma Companies Remain Focused on Prescription Drugs
    • 6.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
    • 6.3.3 OTC Products are Vulnerable to Price Controls by Governments
    • 6.3.4 Downward Cost Pressures of OTC Drugs
  • 6.4 Opportunities
    • 6.4.1 Demographic and Economic Changes Will Create Growth Opportunities
    • 6.4.2 New OTC Switch Categories
    • 6.4.3 Strong Growth in Emerging Markets
    • 6.4.4 New Healthcare Technologies May enable OTC Approvals
    • 6.4.5 Opportunities to Drive Sales via Social Media and Online Marketing
    • 6.4.6 Self-Medication can Reduce the Under Treatment of Disease
  • 6.5 Threats
    • 6.5.1 Competition from Private-Label Brands Will Reduce Profitability
    • 6.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
    • 6.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
  • 6.6 Porter's Five Forces Analysis of the OTC Pharmaceuticals Market
  • 6.7 Rivalry Among Competitors [High]
  • 6.8 Threat of New Entrants [Medium]
  • 6.9 Power of Suppliers [Low]
  • 6.10 Power of Buyers [Medium]
  • 6.11 Threats of Substitutes [Medium]

7. Leading Companies in the OTC Pharmaceuticals Market

  • 7.1 Bayer AG
    • 7.1.1 Bayer AG: Company Overview
    • 7.1.2 Bayer AG: Financial Highlights
    • 7.1.3 Bayer AG: Product Portfolio
    • 7.1.4 Bayer AG: Recent Developments
  • 7.2 GlaxoSmithKline PLC (GSK Consumer Care)
    • 7.2.1 GlaxoSmithKline PLC: Company Overview
    • 7.2.2 GlaxoSmithKline PLC: Financial Highlights
    • 7.2.3 GlaxoSmithKline PLC: Product Portfolio
    • 7.2.4 GlaxoSmithKline PLC: Recent Developments
  • 7.3 Johnson & Johnson
    • 7.3.1 Johnson & Johnson: Company Overview
    • 7.3.2 Johnson & Johnson: Financial Highlights
    • 7.3.3 Johnson & Johnson: Product Portfolio
    • 7.3.4 Johnson & Johnson: Recent Developments
  • 7.4 Perrigo Company PLC
    • 7.4.1 Perrigo Company PLC: Company Overview
    • 7.4.2 Perrigo Company PLC: Financial Highlights
    • 7.4.3 Perrigo Company PLC: Product Portfolio
    • 7.4.4 Perrigo Company PLC: Recent Developments
  • 7.5 Daiichi Sankyo Company, Limited
    • 7.5.1 Daiichi Sankyo Company, Limited: Company Overview
    • 7.5.2 Daiichi Sankyo Company, Limited: Financial Highlights
    • 7.5.3 Daiichi Sankyo Company Limited: Recent Developments
  • 7.6 Pfizer Inc.
    • 7.6.1 Pfizer Inc.: Company Overview
    • 7.6.2 Pfizer Inc.: Financial Highlights
    • 7.6.3 Pfizer Inc.: Product Portfolio
    • 7.6.4 Pfizer Inc.: Recent Developments
  • 7.7 The Procter & Gamble Company
    • 7.7.1 The Procter & Gamble Company: Company Overview
    • 7.7.2 The Procter & Gamble Company: Financial Highlights
    • 7.7.3 The Procter & Gamble Company: Product Portfolio
    • 7.7.4 The Procter & Gamble Company: Recent Developments
  • 7.8 Sanofi S.A.
    • 7.8.1 Sanofi S.A.: Company Overview
    • 7.8.2 Sanofi S.A.: Financial Highlights
    • 7.8.3 Sanofi S.A.: Product Portfolio
    • 7.8.4 Sanofi S.A: Recent Developments
  • 7.9 Reckitt Benckiser Group PLC
    • 7.9.1 Reckitt Benckiser Group PLC: Company Overview
    • 7.9.2 Reckitt Benckiser Group PLC: Financial Highlights
    • 7.9.3 Reckitt Benckiser Group PLC: Product Portfolio
    • 7.9.4 Reckitt Benckiser Group PLC: Recent Developments
  • 7.10 Cipla, Inc.
    • 7.10.1 Cipla Inc.: Company Overview
    • 7.10.2 Cipla Inc.: Financial Highlights
    • 7.10.3 Cipla Inc.: Product Portfolio
    • 7.10.4 Cipla Inc.: Recent Developments
  • 7.11 AstraZeneca plc
    • 7.11.1 AstraZeneca plc: Company Overview
    • 7.11.2 AstraZeneca plc: Financial Highlights
    • 7.11.3 AstraZeneca plc: Product Portfolio
  • 7.12 Bristol Myers Squibb
    • 7.12.1 Bristol Myers Squibb: Company Overview
    • 7.12.2 Bristol Myers Squibb: Financial Highlights
    • 7.12.3 Bristol Myers Squibb: Product Portfolio
  • 7.13 Dr. Reddy's Laboratories Limited
    • 7.13.1 Dr. Reddy's Laboratories Limited: Company Overview
    • 7.13.2 Dr. Reddy's Laboratories Limited: Financial Highlights
    • 7.13.3 Dr. Reddy's Laboratories Limited: Product Portfolio
    • 7.13.4 Dr. Reddy's Laboratories Limited: Recent Developments
  • 7.14 Eisai Co., Ltd.
    • 7.14.1 Eisai Co., Ltd.: Company Overview
    • 7.14.2 Eisai Co., Ltd.: Financial Highlights
    • 7.14.3 Eisai Co., Ltd.: Product Portfolio
  • 7.15 Mylan N.V.
    • 7.15.1 Mylan N.V.: Company Overview
    • 7.15.2 Mylan N.V.: Financial Highlights
    • 7.15.3 Mylan N.V.: Product Portfolio
    • 7.15.4 Mylan N.V.: Recent Developments
  • 7.16 List of Key Players in global OTC Market

8. Conclusions

  • 8.1 The World OTC Pharmaceuticals Market in 2018-2029
    • 8.1.1 The Leading OTC Product Categories
    • 8.1.2 Leading National Markets: Emerging Market Represent a Large Proportion
  • 8.2 The Global OTC Pharmaceuticals Market Growth Factors
    • 8.2.1 Potential OTC Switching, 2018-2029
    • 8.2.2 Emerging OTC Markets
  • 8.3 Concluding Remarks

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain report evaluation form

List of Table

  • Table 3.1 Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.1 Global OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.2 OTC Cough, Cold and Allergy Active Ingredients, 2018
  • Table 4.3 Global OTC Pharmaceuticals Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.4 Global OTC Pharmaceuticals Market for Cough, Cold and Allergy Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.5 OTC Internal Analgesic Active Ingredients, 2018
  • Table 4.6 OTC External Analgesic Active Ingredients, 2018
  • Table 4.7 Global OTC Pharmaceuticals Market for Analgesics Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.8 Global OTC Pharmaceuticals Market for Analgesics Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.9 Global OTC Pharmaceuticals Market for Gastrointestinal Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.10 Global OTC Pharmaceuticals Market for Gastrointestinal Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.11 OTC Antifungal Active Ingredients, 2018
  • Table 4.12 Global OTC Pharmaceuticals Market for Dermatological Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.13 Global OTC Pharmaceutical Market for Dermatological Market Forecast by Geography, ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.14 OTC Dry Eye Syndrome Active Ingredients, 2018
  • Table 4.15 OTC Bacterial Conjunctivitis Active Ingredients, 2018
  • Table 4.16 OTC Ocular Allergy Active Ingredients, 2018
  • Table 4.17 Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.18 Global OTC Pharmaceutical Market for Eye Care Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.19 OTC Smoking Cessation Aid Active Ingredients, 2018
  • Table 4.20 Global OTC Pharmaceuticals Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.21 Global OTC Pharmaceuticals Market for Smoking Cessation Aids Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.22 Global OTC Pharmaceuticals Market for Other Products Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 4.23 Global OTC Pharmaceuticals Market for Other Products Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.1 Global OTC Pharmaceuticals Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.2 North America OTC Pharmaceutical Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.3 USA OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.4 Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.5 Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.6 North America OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.7 South America OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.8 Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.9 Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.10 Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.11 Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.12 Rest of South America OTC Pharmaceuticals Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.13 South America OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.14 European OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.15 Germany OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.16 France OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.17 U.K. OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.18 Italy OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.19 Spain OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.20 Rest of Europe OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.21 Europe OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.22 Asia-Pacific OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.23 Japan OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.24 China OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.25 India OTC Pharmaceuticals Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.26 Australia OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.27 Thailand OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.28 Rest of Asia-Pacific OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.29 Asia-Pacific OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.30 Rest of World OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.31 Middle East OTC Pharmaceuticals Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.32 Africa OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.33 Other Countries OTC Pharmaceuticals Market Forecast: Revenue ($bn, AGR%, CAGR%) 2019-2029
  • Table 5.34 Rest of the World OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
  • Table 7.1 Bayer AG: Company Overview
  • Table 7.2 Bayer AG: Product Portfolio
  • Table 7.3 Bayer AG: Recent Developments
  • Table 7.4 GlaxoSmithKline PLC: Company Overview
  • Table 7.5 GlaxoSmithKline PLC: Product Portfolio
  • Table 7.6 GlaxoSmithKline PLC: Recent Developments
  • Table 7.7 Johnson & Johnson: Company Overview
  • Table 7.8 Johnson & Johnson: Product Portfolio
  • Table 7.9 Johnson & Johnson: Recent Developments
  • Table 7.10 Perrigo Company PLC: Company Overview
  • Table 7.11 Perrigo Company PLC: Product Portfolio
  • Table 7.12 Perrigo Company PLC: Recent Developments
  • Table 7.13 Daiichi Sankyo Company, Limited: Company Overview
  • Table 7.14 Daiichi Sankyo Company Limited: Recent Developments
  • Table 7.15 Pfizer Inc.: Company Overview
  • Table 7.16 Pfizer Inc.: Product Portfolio
  • Table 7.17 Pfizer Inc.: Recent Developments
  • Table 7.18 The Procter & Gamble Company: Company Overview
  • Table 7.19 The Procter & Gamble Company: Product Portfolio
  • Table 7.20 The Procter & Gamble Company: Recent Developments
  • Table 7.21 Sanofi S.A.: Company Overview
  • Table 7.22 Sanofi S.A.: Product Portfolio
  • Table 7.23 Sanofi S.A: Recent Developments
  • Table 7.24 Reckitt Benckiser Group PLC: Company Overview
  • Table 7.25 Reckitt Benckiser Group PLC: Product Portfolio
  • Table 7.26 Reckitt Benckiser Group PLC: Recent Developments
  • Table 7.27 Cipla Inc.: Company Overview
  • Table 7.28 Cipla Inc.: Product Portfolio
  • Table 7.29 Cipla Inc.: Recent Developments
  • Table 7.30 AstraZeneca plc: Company Overview
  • Table 7.31 AstraZeneca plc: Product Portfolio
  • Table 7.32 Bristol Myers Squibb: Company Overview
  • Table 7.33 Bristol Myers Squibb: Product Portfolio
  • Table 7.34 Dr. Reddy's Laboratories Limited: Company Overview
  • Table 7.35 Dr. Reddy's Laboratories Limited: Product Portfolio
  • Table 7.36 Dr. Reddy's Laboratories Limited: Recent Developments
  • Table 7.37 Eisai Co., Ltd.: Company Overview
  • Table 7.38 Eisai Co., Ltd.: Product Portfolio
  • Table 7.39 Mylan N.V.: Company Overview
  • Table 7.40 Mylan N.V.: Product Portfolio
  • Table 7.41 Mylan N.V.: Recent Developments
  • Table 7.42 List of Key Players in Global OTC Pharmaceuticals Marke

List of Figure

  • Figure 2.1 The OTC Pharmaceutical Supply Chain, 2019
  • Figure 3.1 OTC Pharmaceuticals Market by Product: Revenue ($bn), 2019-2029
  • Figure 3.2 OTC Pharmaceutical Market by Geography: Revenue ($bn) 2019-2029
  • Figure 4.1 Global OTC Pharmaceuticals Market by Product; Market Share (%), 2018
  • Figure 4.2 Global OTC Pharmaceuticals Market by Product: Revenue Forecast ($bn) 2019-2029
  • Figure 4.3 Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast by Geography: Revenue ($bn) 2019-2029
  • Figure 4.4 Global OTC Pharmaceuticals Market for Analgesics Market Forecast by Geography: Revenue ($bn) 2019-2029
  • Figure 4.5 Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast by Geography: Revenue ($bn) 2019-2029
  • Figure 4.6 Global OTC Pharmaceuticals Market for Dermatological Market Forecast by Geography: Revenue ($bn) 2019-2029
  • Figure 4.7 Global OTC Pharmaceuticals Market for Eye Care Market Forecast by Geography: Revenue ($bn) 2019-2029
  • Figure 4.8 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast by Geography: Revenue ($bn) 2019-2029
  • Figure 4.9 Global OTC Pharmaceuticals Market for Other Products Market Forecast by Geography: Revenue ($bn) 2019-2029
  • Figure 5.1 Global OTC Pharmaceuticals Market Forecast by Geography: Revenue ($bn) 2019-2029
  • Figure 5.2 Global OTC Pharmaceuticals Market by Geography: Market Share (%), 2018
  • Figure 5.3 North America OTC Pharmaceuticals Market Forecast by Country: Revenue ($bn) 2019-2029
  • Figure 5.4 North America OTC Pharmaceuticals Market by Country: Market Share (%), 2018
  • Figure 5.5 USA OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.6 Canada OTC Pharmaceutical Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.7 Mexico OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.8 North America OTC Pharmaceutical Market Forecast by Product: Revenue ($bn) 2019-2029
  • Figure 5.9 North America OTC Pharmaceutical Market by Product: Market Share (%), 2018
  • Figure 5.10 South America OTC Pharmaceutical Market Forecast by Country ($bn) 2019-2029
  • Figure 5.11 South America OTC Pharmaceuticals Market by Country: Market Share (%), 2018
  • Figure 5.12 Brazil OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.13 Argentina OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.14 Paraguay OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.15 Bolivia OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.16 Rest of South America OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.17 South America OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029
  • Figure 5.18 South America OTC Pharmaceuticals Market by Product: Market Share (%), 2018
  • Figure 5.19 Europe OTC Pharmaceuticals Market Forecast by Country ($bn) 2019-2029
  • Figure 5.20 Europe OTC Pharmaceutical Market by Country: Market Share (%), 2018
  • Figure 5.21 Germany OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.22 France OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.23 U.K. OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.24 Italy OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.25 Spain OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.26 Rest of Europe OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.27 Europe OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029
  • Figure 5.28 Europe OTC Pharmaceuticals Market by Product: Market Share (%), 2018
  • Figure 5.29 Asia-Pacific OTC Pharmaceuticals Market Forecast by Country: Revenue ($bn) 2019-2029
  • Figure 5.30 Asia-Pacific OTC Pharmaceutical Market by Country: Market Share (%), 2018
  • Figure 5.31 Japan OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.32 China OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.33 India OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.34 Australia OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.35 Thailand OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.36 Rest of Asia-Pacific OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.37 Asia-Pacific OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029
  • Figure 5.38 Asia-Pacific OTC Pharmaceutical Market by Product: Market Share (%), 2018
  • Figure 5.39 Rest of the World OTC Pharmaceuticals Market Forecast by Country: Revenue ($bn) 2019-2029
  • Figure 5.40 Rest of the World OTC Pharmaceuticals Market by Country: Market Share (%), 2018
  • Figure 5.41 Middle East OTC Pharmaceuticals Market Forecast ($bn) 2019-2029
  • Figure 5.42 Africa OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.43 Other Countries OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
  • Figure 5.44 Rest of the World OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029
  • Figure 5.45 Rest of the World OTC Pharmaceuticals Market by Product, Market Share (%), 2018
  • Figure 6.1 Porter's Five Analysis of the OTC Pharmaceuticals Market, 2018
  • Figure 7.1 Bayer AG: Revenue ($million), 2014-2018
  • Figure 7.2 Bayer AG: Product Segments Share (%), 2018
  • Figure 7.3 Bayer AG: Geographic Presence Share (%), 2018
  • Figure 7.4 GlaxoSmithKline PLC: Revenue ($million), 2014-2018
  • Figure 7.5 GlaxoSmithKline PLC: Product Segments Share (%), 2018
  • Figure 7.6 GlaxoSmithKline PLC: Geographical Presence Share (%), 2018
  • Figure 7.7 Johnson & Johnson: Revenue ($million), 2014-2018
  • Figure 7.8 Johnson & Johnson: Product Segments Share (%), 2018
  • Figure 7.9 Johnson & Johnson: Geographical Presence Share (%), 2018
  • Figure 7.10 Perrigo Company PLC, Revenue, ($million), 2014-2018
  • Figure 7.11 Perrigo Company PLC: Product Segments Share (%), 2018
  • Figure 7.12 Perrigo Company PLC: Geographical Presence Share (%), 2018
  • Figure 7.13 Daiichi Sankyo Company Limited: Revenue ($million), 2014-2018
  • Figure 7.14 Daiichi Sankyo Company Limited: Geographical Presence Share (%), 2018
  • Figure 7.15 Pfizer Inc.: Revenue ($million), 2014-2018
  • Figure 7.16 Pfizer Inc.: Product Segments Share (%), 2018
  • Figure 7.17 Pfizer Inc.: Geographical Presence Share (%), 2018
  • Figure 7.18 The Procter & Gamble Company: Revenue ($million), 2014-2018
  • Figure 7.19 The Procter & Gamble Company: Product Segments Share (%), 2018
  • Figure 7.20 The Procter & Gamble Company: Geographical Presence Share (%), 2018
  • Figure 7.21 Sanofi S.A.: Revenue ($million), 2014-2018
  • Figure 7.22 Sanofi S.A.: Product Segments Share (%), 2018
  • Figure 7.23 Sanofi S.A.: Geographical Presence Share (%), 2018
  • Figure 7.24 Reckitt Benckiser Group PLC: Revenue ($million), 2014-2018
  • Figure 7.25 Reckitt Benckiser Group PLC: Product Segments Share (%), 2018
  • Figure 7.26 Reckitt Benckiser Group PLC: Geographical Presence Share (%), 2018
  • Figure 7.27 Cipla Inc.: Revenue: ($million), 2014-2018
  • Figure 7.28 Cipla Inc.: Product Segments Share (%), 2018
  • Figure 7.29 AstraZeneca plc: Revenue ($million), 2014-2018
  • Figure 7.30 AstraZeneca plc: Product Segments Share (%), 2018
  • Figure 7.31 AstraZeneca plc: Geographical Presence Share (%), 2018
  • Figure 7.32 Bristol Myers Squibb: Revenue ($million), 2014-2018
  • Figure 7.33 Bristol Myers Squibb: Product Segments Share (%), 2018
  • Figure 7.34 Bristol Myers Squibb: Geographical Presence Share (%), 2018
  • Figure 7.35 Dr. Reddy's Laboratories Limited: Revenue ($million), 2014-2018
  • Figure 7.36 Dr. Reddy's Laboratories Limited: Product Segments Share (%), 2018
  • Figure 7.37 Dr. Reddy's Laboratories Limited: Geographical Presence Share (%), 2018
  • Figure 7.38 Eisai Co., Ltd.: Revenue ($million), 2014-2018
  • Figure 7.39 Eisai Co., Ltd.: Product Segments Share (%), 2018
  • Figure 7.40 Eisai Co., Ltd.: Geographical Presence Share (%), 2018
  • Figure 7.41 Mylan N.V.: Revenue ($million), 2014-2018
  • Figure 7.42 Mylan N.V.: Product Segments Share (%), 2018
  • Figure 7.43 Mylan N.V.: Geographical Presence Share (%), 2018
  • Figure 8.1 Global OTC Pharmaceuticals Market Revenue, by Product Type ($bn), 2019-2029
  • Figure 8.2 Global OTC Pharmaceuticals Market: Revenue by Geography ($bn), 2019-2029

COMPANIES LISTED:

  • 23andMe
  • Abbott Medical Optics
  • Achelios Therapeutics, Inc.
  • Acrux
  • Agrifen
  • AiPing Pharmaceutical
  • Akron Pharmaceuticals
  • Alka Seltzer Vitacilina
  • Allegiant Health
  • Alliance Boots
  • Alvogen pharmaceuticals company
  • American Health
  • AmerisourceBergen
  • Amol Pharmaceuticals Private Limited
  • Apotex
  • Arena Pharmaceuticals
  • Aspen Australia
  • Aspen Global Inc.
  • Aspirina
  • Astellas Pharma US, Inc.
  • AstraZeneca PLC
  • Bal Pharma ltd.
  • Bayer
  • BePharBel
  • Beximco Pharmaceuticals
  • Binnopharm
  • Biocartis Group NV
  • Biocon Ltd.
  • BioGaia
  • BionTech AG
  • Bliss GVS Pharma Ltd.
  • Boehringer Ingelheim
  • Bristol-Myres Squibb
  • Bukwang Pharm. Co., Ltd.
  • Canagen Pharmaceuticals, Inc.
  • Cardinal Health
  • Carlyle Group
  • Catalent Pharma Solutions
  • Celesio
  • China Resources
  • Chr. Hansen
  • Cialis
  • Cleveland Clinic
  • CoLucid Pharmaceuticals
  • CR Pharmaceutical
  • Crescent Pharma
  • Curis, Inc.
  • Daiichi Sankyo
  • Delavau Pharmaceutical Partners
  • Dihon Pharmaceutical Group Co Ltd.
  • Ducere Pharma
  • Eisai Co., Ltd.
  • Electrolit
  • Eli Lilly
  • FameWave Ltd.
  • Flamel
  • Fujifilm Kyowa Kirin Biologics Co. Ltd.
  • GCP Laboratories
  • Genomma Lab
  • GIC Holdings
  • Gilead Medicines
  • GSK
  • Guangzhou Pharmaceutical Company, Ltd.
  • Guardian Drug Company
  • Haplogen GmbH
  • Hiran Agroceuticals Private Limited
  • Hi-Tech Pharmaceuticals
  • Im Co., Ltd
  • iNova Pharmaceuticals
  • Insight
  • Integral Molecular, Inc.
  • Ion Labs
  • Jagdale Healthcare
  • Janssen Pharmaceuticals, Inc.
  • Johnson & Johnson
  • Juno Pharmaceuticals
  • Kowa
  • Lion
  • Lipa Pharmaceuticals
  • LNK International, Inc.
  • Marksans Pharma
  • Mayne Pharma
  • McKesson Corporation
  • MCP3
  • Mead Johnson Nutrition Company
  • Merck
  • Merck Seron
  • Moberg Pharma
  • Momenta Pharmaceuticals, Inc.
  • Morphic Therapeutic
  • Mylan N.V.
  • Nektar Therapeutics
  • Nektar Therapeutics
  • NeoStrata Company, Inc.
  • Nepstar
  • Nexgen Pharma Inc.
  • Next
  • Nihon Eisai Co., Ltd.
  • Novartis JV
  • Olainfarm
  • Olive Healthcare
  • Omega Pharma Invest N.V.
  • Ono Pharmaceutical Co., Ltd.
  • ORJagdale Healthcare SL
  • ORSL
  • Pedialyte
  • Perrigo Company PLC
  • Pfizer
  • Phoenix
  • Procter & Gamble
  • ProPhase Labs, Inc.
  • Purzer Pharmaceutical Co., Ltd.
  • Ranir Global Holdings LLC
  • Reckitt Benckiser
  • Rohto
  • Sal de Uvas Picot
  • Samson Pharmaceuticals, Inc.
  • Sanofi
  • Sarvotham Care Limited
  • Sato
  • Sentiss Pharmaceuticals, LLC
  • Shanghai Pharmaceuticals
  • Sinopharm
  • Sterling Pharmaceutical
  • Suerox
  • Taisho
  • Takeda
  • Target
  • TB Alliance
  • Tempra
  • Teva
  • Theravance Biopharma, Inc.
  • Transgene SA
  • Trividia Manufacturing Solutions, Inc.
  • TSI Pharmaceuticals
  • Valenta Pharm
  • Verily Life Sciences LLC
  • Vifor Pharma
  • Vista Pharmaceuticals
  • Walmart
  • Wellona Pharma

List of Organisations Mentioned in the Report:4

  • ANVISA
  • Association of the European Self-Medication Industry
  • Canadian Institute for Health Information
  • Center for Drug Evaluation and Research
  • European Medicines Agency
  • French Ministry of Health
  • Kyoto University
  • MD Anderson Cancer Center
  • Medicines and Healthcare products Regulatory Agency
  • Ministry of Health, Labour and Welfare
  • Pharmaceutical and Medical Devices Agency
  • Sarah Cannon Research Institute
  • State Food and Drug Administration
Back to Top